# Sarepta Therapeutics plunges 42% premarket after saying it will request expanding its Duchenne muscular dystrophy treatment to patients in all age gro...
**Why is it moving?**

**2023-10-31 11:49**

**https://www.ainvest.com/news/sarepta-therapeutics-plunges-42-premarket-after-saying-it-will-request-expanding-its-duchenne-muscular-dystrophy-treatment-to-patients-in-all-age-groups-following-results-of-a-study-231010000edaad84eaa20328/**

Sarepta Therapeutics plunges 42% premarket after saying it will request expanding its Duchenne muscular dystrophy treatment to patients in all age groups following results of a study